Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Belite Bio, Inc BLTE

Set alert

Price alert · BLTE

All alert types
153.67 USD -1.07 -0.69%

At close · Nov 2

153.67 0.00 0.00%

After hours · Nov 2, 4:00 PM ET

Bid
153.62 × 2
Ask
154.26 × 2
151.14 Day range 157.00
105.76 52-week range 193.61
YTD
-3.93%
1 year
+45.11%
Open
155.08
Prev close
154.74
Mkt cap
6.19B
Vol
114.88K
Avg vol
178.60K
EPS
-2.71
P/E
0.00
Div yield
0.00%
More statistics
Low
151.14
High
157.00
Forward P/E
68.00
Beta
-1.19
Short ratio
7.77
Inst. own
24.27%
Dividend
0.00
Ex-div date
Earnings
Nov 9, 2026
50-d avg
161.47
200-d avg
160.36
1y target
227.44

3M chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Aug 12, 2026Earnings: -0.7; estimate -0.73; surprise 4.11%
  • Aug 14, 2026Rating: Cantor Fitzgerald · Overweight → Overweight
  • Aug 14, 2026Rating: Morgan Stanley · Overweight → Overweight
  • Sep 4, 2026Rating: Canaccord Genuity · — → Buy
  • Sep 8, 2026Rating: HC Wainwright & Co. · Buy → Buy
  • Sep 9, 2026Rating: Mizuho · Outperform → Outperform
  • Oct 15, 2026Rating: HC Wainwright & Co. · Buy → Buy
Signals (16)
NameDateAgo
MACD: Buy SignalOct 29, 20264 days ago
SMA: BearishOct 1, 20261 month ago
SMA: BearishOct 1, 20261 month ago
SMA: BullishSep 30, 20261 month ago
SMA: BearishSep 25, 20261 month ago
MACD: Sell SignalSep 16, 20261 month ago
MACD: Buy SignalSep 4, 20261 month ago
RSI: OverboughtSep 4, 20261 month ago
SMA: BullishSep 2, 20262 months ago
SMA: BullishSep 1, 20262 months ago
SMA: BearishAug 28, 20262 months ago
SMA: BearishAug 26, 20262 months ago
SMA: BullishAug 25, 20262 months ago
SMA: BearishAug 24, 20262 months ago
MACD: Sell SignalAug 18, 20262 months ago
RSI: OverboughtAug 11, 20262 months ago

Financial health

Altman Z-Score

248.70 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

D+1 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -69.2×
FY 2020: -17.1×FY 2021: -26.5×FY 2022: -47.8×FY 2023: -38.4×FY 2024: -53.5×FY 2025: -69.2×
FY 2020 5y median -47.8× FY 2025
P/S 0.0×
FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2020 5y median 0.0× FY 2025
P/B 7.0×
FY 2020: -13.9×FY 2021: -16.9×FY 2022: 14.5×FY 2023: 13.5×FY 2024: 13.2×FY 2025: 7.0×
FY 2020 5y median 13.2× FY 2025
P/FCF -144×
FY 2020: -21.8×FY 2021: -33.8×FY 2022: -50.8×FY 2023: -40.7×FY 2024: -65.6×FY 2025: -144×
FY 2020 5y median -50.8× FY 2025
EV/EBITDA -65.0×
FY 2020: -18.1×FY 2021: -28.0×FY 2022: -45.1×FY 2023: -36.2×FY 2024: -53.2×FY 2025: -65.0×
FY 2020 5y median -45.1× FY 2025
EV/Sales 0.0×
FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2020 5y median 0.0× FY 2025
FCF Yield -0.7%
FY 2020: -4.6%FY 2021: -3.0%FY 2022: -2.0%FY 2023: -2.5%FY 2024: -1.5%FY 2025: -0.7%
FY 2020 5y median -2.0% FY 2025

Profitability

Gross Margin 0.0%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2020 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2020 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2020 5y median 0.0% FY 2025
ROE -10.1%
FY 2020: 81.8%FY 2021: 64.0%FY 2022: -30.5%FY 2023: -35.0%FY 2024: -24.8%FY 2025: -10.1%
FY 2020 5y median -24.8% FY 2025
ROIC -10.9%
FY 2020: -23.2%FY 2021: -58.6%FY 2022: -30.3%FY 2023: -34.7%FY 2024: -27.3%FY 2025: -10.9%
FY 2020 5y median -30.3% FY 2025
ROA -9.9%
FY 2020: -22.3%FY 2021: -52.7%FY 2022: -28.6%FY 2023: -33.4%FY 2024: -23.8%FY 2025: -9.9%
FY 2020 5y median -28.6% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2020 FY 2025
Operating Income -110.5%
FY 2020: 0.0%FY 2021: -70.6%FY 2022: -30.9%FY 2023: -147.0%FY 2024: -26.3%FY 2025: -110.5%
FY 2020 FY 2025
EPS (diluted) -95.8%
FY 2020: 0.0%FY 2021: 35.5%FY 2022: -57.5%FY 2023: -88.9%FY 2024: 0.8%FY 2025: -95.8%
FY 2020 FY 2025
Free Cash Flow -26.5%
FY 2020: 0.0%FY 2021: -69.2%FY 2022: -57.0%FY 2023: -152.3%FY 2024: 1.7%FY 2025: -26.5%
FY 2020 FY 2025

Financial Health

Current Ratio 50.0×
FY 2020: 26.4×FY 2021: 10.7×FY 2022: 20.3×FY 2023: 24.8×FY 2024: 24.3×FY 2025: 50.0×
FY 2020 5y median 24.3× FY 2025
Quick Ratio 50.0×
FY 2020: 26.4×FY 2021: 10.7×FY 2022: 20.3×FY 2023: 24.8×FY 2024: 24.3×FY 2025: 50.0×
FY 2020 5y median 24.3× FY 2025
Debt / Equity 0.0×
FY 2020: -4.5×FY 2021: -2.1×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2020 5y median 0.0× FY 2025
Net Debt / EBITDA 4.6×
FY 2020: -1.1×FY 2021: -1.5×FY 2022: 3.3×FY 2023: 2.8×FY 2024: 0.9×FY 2025: 4.6×
FY 2020 5y median 2.8× FY 2025
Interest Coverage 0.0×
FY 2020: -273×FY 2021: 0.0×FY 2022: -801×FY 2023: -1267×FY 2024: -2000×FY 2025: 0.0×
FY 2020 5y median -801× FY 2025

Dividends

Dividend Yield 0.0%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2020 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2020 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31